Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNeurology Physician in San Francisco, CA
NPI: 1437186855Primary Practice Location
UCSF MEDICAL CENTER
1975 4th St, San Francisco, CA
Primary Employer
UCSF Medical Center
ucsfhealth.org
HQ Phone
Get M.D. Chadwick's Phone Numberphone_androidMobile
Get M.D. Chadwick's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1993 - 2027
American Board of Psychiatry and Neurology
Neurology
Weill Cornell Medicine
weill.cornell.edu
Medical School
Until 1991
UCSF School of Medicine
medschool.ucsf.edu
Internship • Internal Medicine
1991 - 1992
Residency • Neurology
1992 - 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 155 | 214 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 111 | 148 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 92 | 120 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 22 | 22 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 13 | 13 |
Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort.
Authors: Robert Hauser, John Fang, Sotirios Parashos, James Boyd, Zoltan Mari, Grace Liang, David Simon, Tiffini Voss, Stephen Lee, John Morgan, Lewis Sudarsky, Jorge Juncos
Journal: J Neurol Sci
Publication Date: 2017-04-11
Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease.
Authors: Paul Larson, Philip Starr, Michael Aminoff
Journal: Hum Gene Ther
Publication Date: 2012-04-10
Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease
Lead Sponsor: Annovis Bio Inc.
Collaborators: TFS Trial Form Support
Intervention / Treatment: DRUG: Placebo, DRUG: buntanetap/posiphen
Lead Sponsor: Brain Neurotherapy Bio, Inc.
Collaborators: California Institute for Regenerative Medicine (CIRM), AskBio Inc
Intervention / Treatment: BIOLOGICAL: AAV2-GDNF
Lead Sponsor: Neurocrine Biosciences
Collaborators: University of California, San Francisco, Oregon Health and Science University, Veristat, Inc., Feinstein Institute for Medical Research, Voyager Therapeutics
Intervention / Treatment: BIOLOGICAL: VY-AADC01
